Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer

por Kubben, F J G M, Sier, C F M, van Duijn, W, Griffioen, G, Hanemaaijer, R, van de Velde, C J H, van Krieken, J H J M, Lamers, C B H W, Verspaget, H W
Publicado 2006

MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients

por Langers, A M J, Verspaget, H W, Hawinkels, L J A C, Kubben, F J G M, van Duijn, W, van der Reijden, J J, Hardwick, J C H, Hommes, D W, Sier, C F M
Publicado 2012

MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not

por Langers, A M J, Sier, C F M, Hawinkels, L J A C, Kubben, F J G M, van Duijn, W, van der Reijden, J J, Lamers, C B H W, Hommes, D W, Verspaget, H W
Publicado 2008

Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients

por Hawinkels, L J A C, Verspaget, H W, van Duijn, W, van der Zon, J M, Zuidwijk, K, Kubben, F J G M, Verheijen, J H, Hommes, D W, Lamers, C B H W, Sier, C F M
Publicado 2007

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer

por Kubben, F J G M, Sier, C F M, Meijer, M J W, van den Berg, M, van der Reijden, J J, Griffioen, G, van de Velde, C J H, Lamers, C B H W, Verspaget, H W
Publicado 2006